Ignite Creation Date:
2024-05-05 @ 11:58 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00191971
Status:
COMPLETED
Last Update Posted:
2007-11-06
First Post:
2005-09-12
Brief Title:
2nd Line Gemcitabine Monotherapy for Transitional Cell Carcinoma of Urothelium TCC After CDDP Regimen
Sponsor:
Organization:
Eli Lilly and Company